Tag: mathematics
-
New Funds Awarded for Rapid Infection Diagnostics
A developer of faster infection diagnostics is receiving another $8.2 million from an international group supporting solutions to antibiotic resistant microbes.
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…
-
Drug Licensed for Precision Autism Spectrum Therapies
A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress.
-
Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-
Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.
-
NIH Funds Decentralized Rare Disease Data Network
A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency.
-
Trial Underway Assessing Gut Microbiome-Cancer Links
A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer.
-
Infographic – Smart Home Technologies Emerge
While these systems promise a more connected, efficient, and pleasant home, they require continued development of underlying basic technologies.
-
Gut Microbes Shown to Detect Colorectal Cancer
An analysis of gut bacteria and blood samples from patients indicates changes in the microbiome can provide early warnings for colorectal cancer.
-
Precision Meds Shown Effective in Rare Cancer
Results from a clinical trial show patients with rare bile duct tumors respond to an experimental treatment blocking a specific cancer-causing protein.